Marc has completed studies in polymer chemistry at two universities in Germany (Wuppertal, Mainz) and at Cornell University, NY.
17 years with Boehringer Ingelheim (BI) holding positions in:
- Development of transdermal systems and dry powder inhalation products
- Human pharma launch department, implementing large-scale manufacturing processes for BI´s antidiabetics portfolio, managing plant for a cancer product, leading the global human pharma technical operations group
- Corporate Quality Assurance department, responsible for BI´s global supplier audit center and all supply chain related quality management systems
Engaged in working groups for several trade associations for drug shortage and COVID-19 related aspects and acting as industry single-point-of-contact for BI towards the European Medicines Agency for drug shortage reporting.
In addition, lecturer at the University of Applied Sciences in Bingen, Germany, teaching process science and excipients-use for drug products.